Spectrophotometric Quantitative Determination of Cilazapril and Hydrochlorothiazide in Tablets by Chemometric Methods
| dc.contributor.author | Baleanu, D | |
| dc.contributor.author | Dinç, E | |
| dc.contributor.authorID | 56389 | tr_TR |
| dc.contributor.other | 01. Çankaya Üniversitesi | |
| dc.contributor.other | 02.02. Matematik | |
| dc.contributor.other | 02. Fen-Edebiyat Fakültesi | |
| dc.date.accessioned | 2020-04-15T20:09:24Z | |
| dc.date.accessioned | 2025-09-18T15:45:14Z | |
| dc.date.available | 2020-04-15T20:09:24Z | |
| dc.date.available | 2025-09-18T15:45:14Z | |
| dc.date.issued | 2002 | |
| dc.description.abstract | Four chemometric methods were applied to simultaneous determination of cilazapril and hydrochlorothiazide in tablets. Classical least-square (CLS), inverse least-square (ILS), principal component regression (PCR) and partial least-squares (PLS) methods do not need any priori graphical treatment of the overlapping spectra of two drugs in a mixture. For all chemometric calibrations a concentration set of the random mixture consisting of the two drugs in 0.1 M HCl and methanol (1:1) was prepared. The absorbance data in the UV-Vis spectra were measured for the 15 wavelength points (from 222 to 276 nm) in the spectral region 210-290 nm considering the intervals of Deltalambda = 4 nm. The calibration of the investigated methods involves only absorbance and concentration data matrices. The developed calibrations were tested for the synthetic mixtures consisting of two drugs and using the Maple V software the chemometric, calculations were performed. The results of the methods were compared each other as well as with HPLC method and a good agreement was found. (C) 2002 Elsevier Science B.V. All rights reserved. | en_US |
| dc.description.publishedMonth | 10 | |
| dc.identifier.citation | Dinç, E.; Baleanu, Dumitru, "Spectrophotometric quantitative determination of cilazapril and hydrochlorothiazide in tablets by chemometric methods" Journal Of Pharmaceutical And Biomedical Analysis, Vol.30, No.3, pp.715-723, (2002). | en_US |
| dc.identifier.doi | 10.1016/S0731-7085(02)00359-X | |
| dc.identifier.issn | 0731-7085 | |
| dc.identifier.scopus | 2-s2.0-0037201710 | |
| dc.identifier.uri | https://doi.org/10.1016/S0731-7085(02)00359-X | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12416/14534 | |
| dc.language.iso | en | en_US |
| dc.publisher | Pergamon-elsevier Science Ltd | en_US |
| dc.relation.ispartof | 12th International Symposium on Pharmaceutical and Biomedical Analysis -- MAY 13-16, 2001 -- MONTEREY, CALIFORNIA | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | Chemometric Methods | en_US |
| dc.subject | Quantitative Determination | en_US |
| dc.subject | Cilazapril | en_US |
| dc.subject | Hydrochlorothiazide | en_US |
| dc.subject | Tablets | en_US |
| dc.title | Spectrophotometric Quantitative Determination of Cilazapril and Hydrochlorothiazide in Tablets by Chemometric Methods | en_US |
| dc.title | Spectrophotometric quantitative determination of cilazapril and hydrochlorothiazide in tablets by chemometric methods | tr_TR |
| dc.type | Conference Object | en_US |
| dspace.entity.type | Publication | |
| gdc.author.institutional | Baleanu, Dumitru | |
| gdc.author.scopusid | 7003965179 | |
| gdc.author.scopusid | 7005872966 | |
| gdc.author.wosid | Baleanu, Dumitru/B-9936-2012 | |
| gdc.author.wosid | Dinç, Erdal/Aah-6311-2020 | |
| gdc.description.department | Çankaya University | en_US |
| gdc.description.departmenttemp | Ankara Univ, Fac Pharm, Dept Analyt Chem, TR-06100 Ankara, Turkey; Univ Cankaya, Fac Arts & Sci, Dept Math & Comp Sci, TR-06530 Ankara, Turkey; Inst Space Sci, Natl Inst Laser Plasma & Radiat Phys, R-76911 Bucharest, Romania | en_US |
| gdc.description.endpage | 723 | en_US |
| gdc.description.issue | 3 | en_US |
| gdc.description.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
| gdc.description.scopusquality | Q2 | |
| gdc.description.startpage | 715 | en_US |
| gdc.description.volume | 30 | en_US |
| gdc.description.woscitationindex | Conference Proceedings Citation Index - Science - Science Citation Index Expanded | |
| gdc.description.wosquality | Q2 | |
| gdc.identifier.openalex | W2076931643 | |
| gdc.identifier.pmid | 12367697 | |
| gdc.identifier.wos | WOS:000178826400035 | |
| gdc.openalex.fwci | 3.39336956 | |
| gdc.openalex.normalizedpercentile | 0.91 | |
| gdc.openalex.toppercent | TOP 10% | |
| gdc.opencitations.count | 38 | |
| gdc.plumx.crossrefcites | 27 | |
| gdc.plumx.mendeley | 26 | |
| gdc.plumx.newscount | 1 | |
| gdc.plumx.pubmedcites | 4 | |
| gdc.plumx.scopuscites | 68 | |
| gdc.scopus.citedcount | 68 | |
| gdc.wos.citedcount | 59 | |
| relation.isAuthorOfPublication | f4fffe56-21da-4879-94f9-c55e12e4ff62 | |
| relation.isAuthorOfPublication.latestForDiscovery | f4fffe56-21da-4879-94f9-c55e12e4ff62 | |
| relation.isOrgUnitOfPublication | 0b9123e4-4136-493b-9ffd-be856af2cdb1 | |
| relation.isOrgUnitOfPublication | 26a93bcf-09b3-4631-937a-fe838199f6a5 | |
| relation.isOrgUnitOfPublication | 28fb8edb-0579-4584-a2d4-f5064116924a | |
| relation.isOrgUnitOfPublication.latestForDiscovery | 0b9123e4-4136-493b-9ffd-be856af2cdb1 |